MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Meynert Nucleus-related Cortical Thinning in Parkinson’s Disease with Mild Cognitive Impairment

    S.M Rong, Y. Li, B. Li, K. Nie, P. Zhang, TT. Cai, M.J Mei, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: To investigate the associations between NBM/Ch4 volume and cortical thickness in PD. Background: Cognitive impairment in Parkinson’s disease (PD) involves the cholinergic system, especially the…
  • MDS Virtual Congress 2020

    Multimodal EEG-MRI based machine learning model in identifying Parkinson’s disease with mild cognitive impairment

    J.H Zhang, L.J Wang, K. Nie (Guangzhou, China)

    Objective: To evaluate the diagnostic value of quantitative electroencephalogram (qEEG) and structure Magnetic resonance (sMR) in identifying mild cognitive impairment in Parkinson’s disease (PD-MCI) via…
  • MDS Virtual Congress 2020

    Frailty as clinical modulator of brain damage and progression in Parkinson’s disease

    A. Pilotto, A. Lupini, F. Savoldi, F. Conforti, G. Giannì, A. Imarisio, S. Gipponi, E. Cottini, A. Scalvini, S. Masciocchi, S. Nocivelli, R. Grasso, R. Turrone, M. Rizzetti, A. Padovani (Brescia, Italy)

    Objective: To evaluate the prevalence of frailty and correlation with motor and non-motor symptoms as well as MRI atrophy and white matter hyperintensities in Parkinson's…
  • MDS Virtual Congress 2020

    Donepezil for mild cognitive impairment in Parkinson’s disease: A 48-week follow-up study

    K. Baik, S. Kim, S. Kang, Y. Sohn, P. Lee, S. Kang (Seoul, Republic of Korea)

    Objective: To investigate the efficacy of donepezil for mild cognitive impairment (MCI) in Parkinson’s disease (PD). Background: MCI is common in PD. The mechanism of…
  • MDS Virtual Congress 2020

    APOE, TREM2 and LINGO1 genes: A possible implication in cognition in essential tremor in a Tunisian population

    G. Ali Barreh, A. Nasri, S. Zidi, A. Rekik, S. Mrabet, I. Kacem, M. Ben Djebara, R. Gouider (La Manouba, Tunisia)

    Objective: To investigate the effect of polymorphisms in APOE, TREM2 and LINGO1 genes on the cognitive profile of essential tremor(ET) in Tunisian population. Background: ET…
  • 2019 International Congress

    Subcortical atrophy is an early event in Huntington’s disease

    N. Rocha, L. Latham, O. Charron, G. Papadimitropoulos, G. Colpo, L. Freeman, E. Furr Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To determine whether brain regional volumes are associated with clinical symptoms in premanifest and manifest Huntington’s disease (HD). Background: Striatal atrophy has been considered a…
  • 2019 International Congress

    The cognitive profiles differ among freezing of gait subtypes in Parkinson’s disease

    J. Longhurst, J. Caldwell, A. Ritter, V. Mishra, B. Bluett, M. Landers (Las Vegas, NV, USA)

    Objective: Analyze differences in cognitive profiles among freezing of gait (FOG) subtypes in Parkinson’s disease (PD). Background: FOG in PD has been shown to be…
  • 2019 International Congress

    Influence of peripheral immune system on cognitive profile in Parkinson’s disease

    L. Magistrelli, E. Storelli, V. Milner, E. Rasini, F. Marino, M. Cosentino, C. Comi (Varese, Italy)

    Objective: To investigate the influence of the peripheral immune profile in the development of cognitive impairment in PD. Background: Dementia is frequent in advanced Parkinson’s…
  • 2019 International Congress

    Correlation of P300 parameters with cognition and impulse control disorders in patients with idiopathic Parkinson’s disease

    R. Kandadai, R. Annakula, S. Sarva, S. Meka, T. Syed, S. Tandra, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To evaluate prevalence of impulse control disorders in patients with Parkinson's disease(PD), assess P300 latencies and look for any correlation between P300 latencies and…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in Parkinson’s disease

    A. Amara, K. Wood, A. Joop, R. Memon, J. Pilkington, M. Bamman, C. Hurt (Birmingham, AL, USA)

    Objective: Investigate relationship between cognitive performance and mobility in persons with Parkinson’s disease (PD). Background: Persons with PD experience both motor and non-motor symptoms. Two…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley